Indo SMC SME
smeOngoing
GMP
₹32

smeOngoing
Indo SMC SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹32
(+21.48%) Est. Gain
Investment Timeline
✓
IPO Open
13 Jan 2026
🔒
IPO Close
15 Jan 2026
🎲
Allotment
16 Jan 2026
🔔
Listing
20 Jan 2026
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
NEUTRAL
54/100
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
⚠️ Below average subscription - limited investor appetite
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
📈 Moderate listing gains possible (5-12%)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹141.0 - ₹149.0
📦Lot Size
1000 shares
💰Issue Size
₹87.34 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Indo SMC SME?
As of today, the Grey Market Premium (GMP) for Indo SMC SME is ₹32, which is approximately (+21.48%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Indo SMC SME?
Our AI algorithm currently rates this IPO as "NEUTRAL" with a score of 54/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Indo SMC SME be announced?
The allotment status for Indo SMC SME is expected to be finalized on 16 Jan 2026. Investors can check their status on the registrar's website.
What is the listing date for Indo SMC SME?
Shares of Indo SMC SME are proposed to be listed on stock exchanges on 20 Jan 2026.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.